When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HUMA - Humacyte: Revenue Ramp From Symvess Incoming
Humacyte Inc.
2025-06-11 09:05:31 ET
Humacyte ( HUMA ), the Durham, North Carolina-based biotech company founded in 2004, develops and manufacturers bioengineered human blood vessels and tissues for the treatment (repair and replacement) of various vascular conditions. They have one product in the market, Symvess, which I’ll discuss in more detail below. The company has seen its share price fall significantly since 2021, when it completed its reverse merged via SPAC Alpha Healthcare Acquisition Corp. It remains a high risk but potentially high reward stock....